Duloxetine in the treatment of adolescents with somatoform disorders: a report of two cases.
Actas Esp Psiquiatr
; 40(3): 165-8, 2012.
Article
em En
| MEDLINE
| ID: mdl-22723136
ABSTRACT
BACKGROUND:
Our goal was to evaluate the effectiveness, safety and tolerability of duloxetine in the treatment of children and adolescents with somatoform disorder.RESULTS:
We describe two cases, those of an 11-year old girl and a 17-year old boy, evaluated in our Department after being studied by a Pediatrician and Neuropediatrician due to complex physical symptoms. The evaluations to rule out medical causes were normal. We diagnosed somatoform disorder. The pharmacological treatments with antidepressants, benzodiazepines, stimulants and mood stabilizers only produced brief and partial improvement. After switching the treatment to duloxetine (30 and 60 mg/day, respectively) both patients experienced a gradual improvement that was maintained at 7 and 14 months. Conclusion. Duloxetine may be effective and well tolerated in the treatment of adolescents with somatoform disorder. Controlled trials are need.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Transtornos Somatoformes
/
Tiofenos
/
Inibidores Seletivos de Recaptação de Serotonina
Limite:
Adolescent
/
Child
/
Female
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article